Landec Corporation Sets Fourth Quarter and Fiscal Year-End 2014 Conference Call for July 30, 2014 at 8 a.m. PT and Earnings Release Set for July 29, 2014 After Market

company logo

MENLO PARK, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, July 30, 2014 at 8 a.m. Pacific time to discuss its results for the fourth quarter and fiscal year-end 2014. Financial results will be reported for the 2014 fiscal fourth quarter and fiscal year ended May 25, 2014 after market close on July 29, 2014.

Landec's Chairman and CEO, Gary T. Steele, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.

Date: Wednesday, July 30, 2014
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: 866-253-5757
U.S. and International Toll Number: 703-639-1206
Conference ID: 1641330

The webcast will be available for 30 days through August 30, 2014.

A replay of the teleconference will be available for one week until midnight Eastern Time, Wednesday, August 6, 2014.

Toll free replay dial in: 888-266-2081
International replay: 703-925-2533
Replay passcode: 1641330

About Landec Corporation

Landec Corporation is a materials science company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec's subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology and the strength of two major national brands, Eat Smart® and GreenLine®, with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP validated manufacturing facility for supplying commercial, clinical and pre-clinical products. For more information about the company, visit Landec's website at

CONTACT: Media and Industry Contact: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: Liolios Group, Inc. Matt Glover or Michael Koehler 949-574-3860

Source:Landec Corporation